Invasive Multimodality Neuromonitoring to Manage Cerebral Edema in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

• Published in: Critical care explorations Vol. 5; no. 11; p. e1003
• Main Authors: Fainberg, Nina A., Silver, Maya R., Arena, John D., Landzberg, Elizabeth I., Banwell, Brenda, Gambrah-Lyles, Claudia, Kirschen, Matthew P., Madsen, Peter J., McLendon, Loren, Narula, Sona, Tucker, Alexander M., Huh, Jimmy W., Kienzle, Martha F.
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 02.11.2023; Wolters Kluwer
• Subjects: Case Report
• ISSN: 2639-8028; 2639-8028
• DOI: 10.1097/CCE.0000000000001003

Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder of the CNS with a variety of clinical manifestations, including cerebral edema. Case Summary: A 7-year-old boy presented with headaches, nausea, and somnolence. He was found to have cerebral edema that progressed to brainstem herniation. Invasive multimodality neuromonitoring was initiated to guide management of intracranial hypertension and cerebral hypoxia while he received empiric therapies for neuroinflammation. Workup revealed serum myelin oligodendrocyte glycoprotein antibodies. He survived with a favorable neurologic outcome. Conclusion: We describe a child who presented with cerebral edema and was ultimately diagnosed with MOGAD. Much of his management was guided using data from invasive multimodality neuromonitoring. Invasive multimodality neuromonitoring may have utility in managing life-threatening cerebral edema due to neuroinflammation.